Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $86.7 million.

  • Cellebrite DI's Operating Expenses rose 2050.33% to $86.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.4 million, marking a year-over-year increase of 1943.19%. This contributed to the annual value of $281.7 million for FY2024, which is 1804.46% up from last year.
  • Latest data reveals that Cellebrite DI reported Operating Expenses of $86.7 million as of Q3 2025, which was up 2050.33% from $81.2 million recorded in Q2 2025.
  • Cellebrite DI's Operating Expenses' 5-year high stood at $86.7 million during Q3 2025, with a 5-year trough of $40.7 million in Q1 2021.
  • Its 5-year average for Operating Expenses is $61.8 million, with a median of $58.7 million in 2023.
  • Per our database at Business Quant, Cellebrite DI's Operating Expenses surged by 6406.77% in 2021 and then crashed by 69.38% in 2023.
  • Quarter analysis of 5 years shows Cellebrite DI's Operating Expenses stood at $51.3 million in 2021, then rose by 1.85% to $52.2 million in 2022, then rose by 20.85% to $63.1 million in 2023, then increased by 19.97% to $75.7 million in 2024, then grew by 14.57% to $86.7 million in 2025.
  • Its Operating Expenses stands at $86.7 million for Q3 2025, versus $81.2 million for Q2 2025 and $77.8 million for Q1 2025.